KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNA) Invested Capital (2019 - 2025)

Historic Invested Capital for Ginkgo Bioworks Holdings (DNA) over the last 7 years, with Q3 2025 value amounting to $559.8 million.

  • Ginkgo Bioworks Holdings' Invested Capital fell 2984.67% to $559.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $559.8 million, marking a year-over-year decrease of 2984.67%. This contributed to the annual value of $716.1 million for FY2024, which is 3473.48% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Invested Capital stood at $559.8 million for Q3 2025, which was down 2984.67% from $613.0 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Invested Capital ranged from a high of $1.7 billion in Q4 2022 and a low of $356.4 million during Q2 2021
  • In the last 5 years, Ginkgo Bioworks Holdings' Invested Capital had a median value of $1.1 billion in 2023 and averaged $1.1 billion.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Invested Capital surged by 34112.6% in 2022 and then crashed by 4459.43% in 2024.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Invested Capital stood at $1.6 billion in 2021, then increased by 10.95% to $1.7 billion in 2022, then crashed by 36.91% to $1.1 billion in 2023, then tumbled by 34.73% to $716.1 million in 2024, then decreased by 21.82% to $559.8 million in 2025.
  • Its Invested Capital stands at $559.8 million for Q3 2025, versus $613.0 million for Q2 2025 and $647.4 million for Q1 2025.